FENITOINA SODICA ACCORD 50 mg/ml Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fenitoina sodica accord 50 mg/ml

accord healthcare limited - marea britanie - phenytoinum - sol inj./perf. - 50mg/ml - antiepileptice derivati de hidantoina

CERETEC 500 micrograme (vezi V09AA01) Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ceretec 500 micrograme (vezi v09aa01)

ge healthcare limited - marea britanie - tc 99 m - celule marcate cu exametazinum - trusa (kit) pt. preparat radiofarmaceutic - 500micrograme - agenti pentru decelarea inflamatiei si infectiei compusi cu technetium tc99

FLUDARABINA ACCORD 25 mg/ml Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fludarabina accord 25 mg/ml

accord healthcare limited - marea britanie - fludarabinum - conc. pt. sol. inj. sau perf. - 25mg/ml - antimetaboliti analogi ai bazelor purinice

PLOTIS 30 mg Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

plotis 30 mg

medochemie limited - cipru - dapoxetinum - compr. film. - 30mg - alte preparate urologice (incl. antispastice) alte preparate urologice

PLOTIS 60 mg Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

plotis 60 mg

medochemie limited - cipru - dapoxetinum - compr. film. - 60mg - alte preparate urologice (incl. antispastice) alte preparate urologice

BANXIOL 5 mg Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

banxiol 5 mg

mcdermott laboratories limited trading - irlanda - apixabanum - compr. film. - 5mg - antitrombotice antitrombotice

BANXIOL 5 mg Румыния - румынский - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

banxiol 5 mg

mcdermott laboratories limited trading - irlanda - apixabanum - compr. film. - 5mg - antitrombotice antitrombotice

Dapagliflozin Viatris Европейский союз - румынский - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.